Alibaba’s stock has been on a volatile ride this year, leaving investors both hopeful and jittery. It rose 46.83% ...

Palantir is charging full throttle into AI-driven defense and government operations with two headline initiatives. The ...

Mizuho hiked its price target for AMD from $135 to $152 and kept its “outperform” rating, fueling investor optimism. Several ...

Analysts have handed AbbVie a consensus “Moderate Buy” rating, reflecting cautious optimism about its future performance. Out ...

Eli Lilly’s blockbuster GLP-1 drugs dominate headlines, but its broader portfolio deserves a standing ovation for driving ...

A securities class action targets UnitedHealth over alleged fraud hurting investors from December 2024 to April 2025. Levi & ...

Lodestone Wealth Management trimmed its Home Depot stake by 14% in Q1, selling 708 shares, leaving 4,341 remaining. Several ...

Strategic Blueprint LLC increased its Salesforce stake by 13.5% in Q1, reaching 23,828 shares worth $6.39 million. Hedge ...

Principal Financial Group reduced its Adobe stake by 8.3% in Q1, selling over 57,000 shares worth $242 million. Several ...

Merck shares dropped 1.7% Friday, trading below average volume, as analysts adjusted ratings and investors took profits. Wall ...

Calamos Advisors cranked up its PepsiCo investment by 24.8%, snagging nearly 247,000 shares worth about $37 million. Other ...

First Horizon Advisors increased its holdings in Johnson & Johnson by 5% in the first quarter, adding over 12,000 shares.